Physician profile
Ali Aral
NPI 1932780566
$919.09
in general payments reported to CMS, 2019-2025
7 companies · $370 in 2025
The $370 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $549 · 2025: $370.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $687 · Travel and Lodging: $133 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.17 |
| Travel and Lodging | $132.92 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $212.85 | 2024-2025 | |
| Polynovo North America LLC | $152.47 | 2025 | Novosorb Btm |
| Bioventus LLC | $149.10 | 2024 | Exogen Ultrasound Bone Healing System |
| Medical Device Business Services, INC. | $132.92 | 2024 | Matrixcombo |
| Axogen | $116.02 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Motiva USA, LLC | $103.44 | 2025 | |
| Depuy Synthes Sales INC. | $52.29 | 2024 | Matrixmandible, Matrixmidface, Trumatch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Aral listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.